American journal of hematology
Journal
Overview
publication venue for
-
Erythropoietin-secreting metanephric adenoma presenting as erythrocytosis.
2023
-
Angioimmunoblastic T-cell lymphoma presenting with severe plasmacytosis mimicking plasma cell leukemia.
2023
-
Acute Hemolytic Anemia After Hematopoietic Stem Cell Transplantation: An Unusual Invader.
2023
-
Disseminated intravascular coagulation due to cytomegalovirus infection in an immunocompetent adult treated with plasma exchange.
2006
-
Lymphoma of host origin in a marrow transplant recipient in remission of acute myeloid leukemia and receiving cyclosporin A.
1985
-
Unusual intracytoplasmic inclusions in acute myeloblastic leukemia.
1980
-
Inherited combined deficiency of factor V and factor VIII: report of a case with normal factor VIII antigen and ristocetin-induced platelet aggregation.
1977
-
The Lymphoma Epidemiology of Outcomes cohort study: Design, baseline characteristics, and early outcomes.
2024
-
Prospective analysis to determine barriers to allogeneic hematopoietic cell transplantation in patients with acute leukemia.
2023
-
Measurable residual disease monitoring in patients with acute myeloid leukemia treated with lower-intensity therapy: Roadmap from an ELN-DAVID expert panel.
2023
-
Older patients with primary central nervous system lymphoma: Survival and prognostication across 20 U.S. cancer centers.
2023
-
Assessment of renal outcome following therapy in monoclonal immunoglobulin deposition disease: Emphasizing the need for a consensus approach.
2023
-
Molecular predictors of immunophenotypic measurable residual disease clearance in acute myeloid leukemia..
98.
2022
-
Romiplostim use in pregnant women with immune thrombocytopenia.
2022
-
Cytogenetic risk classification maintains its prognostic significance in transplanted FLT3-ITD mutated acute myeloid leukemia patients: On behalf of the acute leukemia working party/European society of blood and marrow transplantation..
97.
2022
-
Carfilzomib and dexamethasone induction with lenalidomide, clarithromycin and dexamethasone consolidation and lenalidomide maintenance for newly diagnosed multiple myeloma..
96.
2021
-
Multi-center analysis of practice patterns and outcomes of younger and older patients with mantle cell lymphoma in the rituximab era.
2021
-
Romidepsin and lenalidomide-based regimens have efficacy in relapsed/refractory lymphoma: Combined analysis of two phase I studies with expansion cohorts..
96.
2021
-
Comprehensive phenotyping of erythropoiesis in human bone marrow: Evaluation of normal and ineffective erythropoiesis..
96.
2021
-
Venetoclax combinations induce high response rates in newly diagnosed acute myeloid leukemia patients ineligible for intensive chemotherapy in routine practice..
96.
2021
-
A phase 1b study of once-weekly carfilzomib combined with lenalidomide and dexamethasone in patients with newly diagnosed multiple myeloma..
96.
2020
-
Insufficient evidence exists to use histopathologic subtype to guide treatment of idiopathic multicentric Castleman disease..
95.
2020
-
Cytogenetic risk score maintains its prognostic significance in AML patients with detectable measurable residual disease undergoing transplantation in remission: On behalf of the acute leukemia working party of the European society for blood and marrow transplantation.
2020
-
Fedratinib in patients with myelofibrosis previously treated with ruxolitinib: An updated analysis of the JAKARTA2 study using stringent criteria for ruxolitinib failure..
95.
2020
-
Bortezomib consolidation or maintenance following immunochemotherapy and autologous stem cell transplantation for mantle cell lymphoma: CALGB/Alliance 50403..
95.
2020
-
Diagnostic workup of acute leukemias of ambiguous lineage..
95.
2020
-
A multicenter retrospective study of 223 patients with t(14;16) in multiple myeloma..
95.
2020
-
Hemoglobin levels and coronary heart disease risk by age, race, and sex in the reasons for geographic and racial differences in stroke study (REGARDS)..
95.
2019
-
Stability and uniqueness of clonal immunoglobulin CDR3 sequences for MRD tracking in multiple myeloma..
94.
2019
-
Hematogenous extramedullary relapse in multiple myeloma - a multicenter retrospective study in 127 patients..
94.
2019
-
High NPM1 mutant allele burden at diagnosis correlates with minimal residual disease at first remission in de novo acute myeloid leukemia..
94.
2019
-
Second-line treatments in children with immune thrombocytopenia: Effect on platelet count and patient-centered outcomes..
94.
2019
-
Single agents vs combination chemotherapy in relapsed and refractory peripheral T-cell lymphoma: Results from the comprehensive oncology measures for peripheral T-cell lymphoma treatment (COMPLETE) registry..
94.
2019
-
Integration of transcriptional and mutational data simplifies the stratification of peripheral T-cell lymphoma..
94.
2019
-
Phase II study of carfilzomib and dexamethasone therapy for newly diagnosed multiple myeloma..
94.
2019
-
Changes in health-related quality of life with long-term eltrombopag treatment in adults with persistent/chronic immune thrombocytopenia: Findings from the EXTEND study..
94.
2018
-
Duvelisib, an oral dual PI3K-δ,γ inhibitor, shows clinical and pharmacodynamic activity in chronic lymphocytic leukemia and small lymphocytic lymphoma in a phase 1 study..
93.
2018
-
Inverse relationship of serum albumin to the risk of venous thromboembolism among acutely ill hospitalized patients: Analysis from the APEX trial..
94.
2018
-
Genomic and clinical characterization of B/T mixed phenotype acute leukemia reveals recurrent features and T-ALL like mutations..
93.
2018
-
Outcomes of front-line ibrutinib treated CLL patients excluded from landmark clinical trial..
93.
2018
-
Prognosis of patients with intermediate risk IPSS-R myelodysplastic syndrome indicates variable outcomes and need for models beyond IPSS-R..
93.
2018
-
Duvelisib, an oral dual PI3K-δ, γ inhibitor, shows clinical activity in indolent non-Hodgkin lymphoma in a phase 1 study..
93.
2018
-
Fostamatinib for the treatment of adult persistent and chronic immune thrombocytopenia: Results of two phase 3, randomized, placebo-controlled trials..
93.
2018
-
Physician decision making in selection of second-line treatments in immune thrombocytopenia in children..
93.
2018
-
T-cell replete haploidentical stem cell transplantation attenuates the prognostic impact of FLT3-ITD in acute myeloid leukemia: A report from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation..
93.
2018
-
Donor age determines outcome in acute leukemia patients over 40 undergoing haploidentical hematopoietic cell transplantation..
93.
2017
-
Safety and pharmacokinetics of the oral iron chelator SP-420 in β-thalassemia..
92.
2017
-
European LeukemiaNet study on the reproducibility of bone marrow features in masked polycythemia vera and differentiation from essential thrombocythemia..
92.
2017
-
Thiotepa-based conditioning versus total body irradiation as myeloablative conditioning prior to allogeneic stem cell transplantation for acute lymphoblastic leukemia: A matched-pair analysis from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation..
92.
2017
-
ABO incompatibility in mismatched unrelated donor allogeneic hematopoietic cell transplantation for acute myeloid leukemia: A report from the acute leukemia working party of the EBMT..
92.
2017
-
IgM myeloma: A multicenter retrospective study of 134 patients..
92.
2017
-
Long term impact of hyperleukocytosis in newly diagnosed acute myeloid leukemia patients undergoing allogeneic stem cell transplantation: An analysis from the acute leukemia working party of the EBMT..
92.
2017
-
Clinical outcomes in a cohort of patients with heparin-induced thrombocytopenia..
92.
2017
-
Impact of FAB classification on predicting outcome in acute myeloid leukemia, not otherwise specified, patients undergoing allogeneic stem cell transplantation in CR1: An analysis of 1690 patients from the acute leukemia working party of EBMT..
92.
2017
-
Clinical characteristics and outcomes of patients with Hodgkin lymphoma with central nervous system involvement: An international multicenter collaboration..
91.
2016
-
Gender and duration of disease differentiate responses to rituximab-dexamethasone therapy in adults with immune thrombocytopenia..
91.
2016
-
De novo CD5+ diffuse large B-cell lymphoma: Adverse outcomes with and without stem cell transplantation in a large, multicenter, rituximab treated cohort..
91.
2016
-
Disease, treatment, and outcome differences between men and women with follicular lymphoma in the United States..
91.
2016
-
Long-term evaluation of cardiac and vascular toxicity in patients with Philadelphia chromosome-positive leukemias treated with bosutinib..
91.
2016
-
Routine interim disease assessment in patients undergoing induction chemotherapy for acute myeloid leukemia: Can we do better?.
91.
2016
-
Comparing the prognostic value of risk stratifying models for patients with lower-risk myelodysplastic syndromes: Is one model better?.
90.
2015
-
Red blood cell transfusion is associated with increased hemolysis and an acute phase response in a subset of critically ill children..
90.
2015
-
Cardiovascular and pulmonary adverse events in patients treated with BCR-ABL inhibitors: Data from the FDA Adverse Event Reporting System..
90.
2015
-
Effect of thrombopoietin receptor agonists on the apoptotic profile of platelets in patients with chronic immune thrombocytopenia..
89.
2014
-
Allogeneic stem cell transplantation as initial salvage for patients with acute myeloid leukemia refractory to high-dose cytarabine-based induction chemotherapy..
89.
2014
-
Subcutaneous versus intravenous granulocyte colony stimulating factor for the treatment of neutropenia in hospitalized hemato-oncological patients: randomized controlled trial..
89.
2014
-
Pregnancy outcomes in women with thalassemia in North America and the United Kingdom..
88.
2013
-
Transcriptomic and phospho-proteomic analyzes of erythroblasts expanded in vitro from normal donors and from patients with polycythemia vera..
88.
2013
-
Longitudinal monitoring of cardiac siderosis using cardiovascular magnetic resonance T2* in patients with thalassemia major on various chelation regimens: a 6-year study..
88.
2013
-
Regulatory B-cell compartment in transfused alloimmunized and non-alloimmunized patients with sickle cell disease..
88.
2013
-
Exploring the amyloid proteome in immunoglobulin-derived lymph node amyloidosis using laser microdissection/tandem mass spectrometry..
88.
2013
-
Predictive factors for successful imatinib cessation in chronic myeloid leukemia patients treated with imatinib..
88.
2013
-
Allogeneic hematopoietic stem cell transplantation versus hypomethylating agents in patients with myelodysplastic syndrome: a retrospective case-control study..
88.
2013
-
Immunoparesis and monoclonal gammopathy of undetermined significance are disassociated in advanced age..
88.
2012
-
The clinical spectrum of Castleman's disease..
87.
2012
-
Germline variation in complement genes and event-free survival in follicular and diffuse large B-cell lymphoma..
87.
2012
-
Elevated pretreatment serum levels of interferon-inducible protein-10 (CXCL10) predict disease relapse and prognosis in diffuse large B-cell lymphoma patients..
87.
2012
-
Predictors of prolonged survival after allogeneic hematopoietic stem cell transplantation for multiple myeloma..
87.
2012
-
Immune regulation in chronically transfused allo-antibody responder and nonresponder patients with sickle cell disease and β-thalassemia major..
86.
2011
-
Iron chelation adherence to deferoxamine and deferasirox in thalassemia..
86.
2011
-
Prognostic factors in patients with HIV-associated peripheral T-cell lymphoma: a multicenter study..
86.
2011
-
Clarithromycin (Biaxin)-lenalidomide-low-dose dexamethasone (BiRd) versus lenalidomide-low-dose dexamethasone (Rd) for newly diagnosed myeloma..
85.
2010
-
The outcome of IgD myeloma after autologous hematopoietic stem cell transplantation is similar to other Ig subtypes..
85.
2010
-
Repeated courses of rituximab in chronic ITP: Three different regimens..
84.
2009
-
Synergistic antitumor effects of lenalidomide and rituximab on mantle cell lymphoma in vitro and in vivo..
84.
2009
-
Tumor-associated macrophages infiltrate plasmacytomas and can serve as cell carriers for oncolytic measles virotherapy of disseminated myeloma..
84.
2009
-
Poor hematopoietic stem cell mobilizers: a single institution study of incidence and risk factors in patients with recurrent or relapsed lymphoma..
84.
2009
-
Self-reported health-related quality of life in adults with chronic immune thrombocytopenic purpura..
83.
2008
-
Combined neonatal blood transplants in a parent-to-F1 mouse model: improved survival rates and stable long-term engraftment..
82.
2007
-
Reduced intensity compared with high dose conditioning for allotransplantation in acute myeloid leukemia and myelodysplastic syndrome: a comparative clinical analysis..
82.
2007
-
Superior effect of intravenous anti-D compared with IV gammaglobulin in the treatment of HIV-thrombocytopenia: results of a small, randomized prospective comparison..
82.
2007
-
Morbidity and mortality in chronically transfused subjects with thalassemia and sickle cell disease: A report from the multi-center study of iron overload..
82.
2007
-
Safety and tolerability of a novel chromatography-based intravenous immunoglobulin when administered at a high infusion rate in patients with immune thrombocytopenic purpura..
82.
2007
-
Efficacy of high-dose therapy and hematopoietic stem cell transplantation for mantle cell lymphoma..
81.
2006
-
Efficacy of mycophenolate mofetil as single-agent therapy for refractory immune thrombocytopenic purpura..
81.
2006
-
Ikaros increases normal apoptosis in adult erythroid cells..
81.
2006
-
Prospective evaluation of a new platelet glycoprotein (GP)-specific assay (PakAuto) in the diagnosis of autoimmune thrombocytopenia (AITP)..
78.
2005
-
Prospective screening of 205 patients with ITP, including diagnosis, serological markers, and the relationship between platelet counts, endogenous thrombopoietin, and circulating antithrombopoietin antibodies..
76.
2004
-
Zileuton, a 5-lipoxygenase inhibitor, increases production of thromboxane A2 and platelet aggregation in patients with asthma..
74.
2003
-
Long term follow-up after splenectomy performed for immune thrombocytopenic purpura (ITP)..
72.
2003
-
Thiotepa, busulfan, and cyclophosphamide as a preparative regimen for allogeneic transplantation for advanced myelodysplastic syndrome and acute myelogenous leukemia..
67.
2001
-
Do the acute platelet responses of patients with immune thrombocytopenic purpura (ITP) to IV anti-D and to IV gammaglobulin predict response to subsequent splenectomy?.
67.
2001
-
A pilot study of rhuIL-11 treatment of refractory ITP..
66.
2001
-
Prevalence of HTLV-I-associated T-cell lymphoma..
66.
2001
-
Role of transforming growth factor beta1 in microvascular endothelial cell apoptosis associated with thrombotic thrombocytopenic purpura and hemolytic-uremic syndrome..
66.
2001
-
Is it necessary to test patients with immune thrombocytopenic purpura (ITP) for seropositivity to HTLV-1?.
61.
1999
-
Serum transferrin receptor as a marker of erythropoiesis suppression in patients on chronic transfusion..
60.
1999
-
Role of caspases 1 and 3 and Bcl-2-related molecules in endothelial cell apoptosis associated with thrombotic microangiopathies..
59.
1998
-
Increased von Willebrand factor binding to platelets in single episode and recurrent types of thrombotic thrombocytopenic purpura..
57.
1998
-
Dissection of the association status of two polymorphisms in the beta-globin gene cluster with variations in F-cell number in non-anemic individuals..
56.
1997
-
Pilot study of 5-azacytidine (5-AZA) and carboplatin (CBDCA) in patients with relapsed/refractory leukemia..
51.
1996
-
Haplotypes of the human beta-like globin gene cluster: analyzing the 3' Hpa I polymorphic site by long distance PCR..
50.
1995
-
Allogeneic bone marrow transplantation for leukemia following piperazinedione and fractionated total body irradiation..
46.
1994
-
Efficacy of intravenous immunoglobulin in the treatment of autoimmune hemolytic anemia: results in 73 patients..
44.
1993
-
Synergistic effect of heme and IL-1 on hematopoietic stromal regeneration after radiation..
44.
1993
-
Elevated levels of heme oxygenase-1 activity and mRNA in peripheral blood adherent cells of acquired immunodeficiency syndrome patients..
43.
1993
-
Phorbol ester-induced hairy cell features on chronic lymphocytic leukemia cells in vitro..
40.
1992
-
Protein C and S levels in acute leukemia..
37.
1991
-
Alternation of two doses of intravenous gammaglobulin in the maintenance treatment of patients with immune thrombocytopenic purpura: more is not always better..
33.
1990
-
Isolated thrombocytopenia in patients infected with HIV: treatment with intravenous gammaglobulin..
28.
1988
-
Clonal immunoglobulin gene rearrangements in chronic lymphocytic leukemia: a correlative study..
27.
1988
-
The first report of familial adult T-cell leukemia lymphoma in the United States..
27.
1988
-
Measurement of terminal deoxynucleotidyl transferase mRNA in clinical samples: a new parameter in analysis of leukemia cells..
25.
1987
-
Porphyria cutanea tarda associated with the acquired immune deficiency syndrome..
25.
1987
-
Phenotypic heterogeneity of human T-cell malignancies: demonstration by monoclonal antibodies and cytochemical markers..
12.
1982
-
Plasma beta-thromboglobulin values in thrombocytopenic patients with acute leukemia..
8.
1980
-
Relationship of SV40 T-antigen expression in vitro to disorders of bone marrow function..
8.
1980
-
Subpopulations of human peripheral blood cells: analysis of granulocytic progenitor cells by flow cytometry and immunologic surface markers..
7.
1979
-
Coulter S hematocrit and microhematocrit in polycythemic patients..
5.
1978
-
Guidelines for protocol studies in chronic lymphocytic leukemia..
4.
1978
-
The treatment of combination chemotherapy-resistant Hodgkin disease with single-agent vinblastine..
4.
1978
-
Effect of prior radiotherapy on tolerance and response to chemotherapy in non-Hodgkin's lymphoma..
2.
1977
-
SV40 T-antigen expression in skin fibroblasts from clinically normal individuals and from ten cases of Fanconi anemia..
2.
1977
-
Two p53s in a Pod: Co-occurring plasma cell myeloma and therapy-related myeloid neoplasm following lenalidomide therapy.
2023
-
Myelodysplastic syndromes with no somatic mutations detected by next-generation sequencing display similar features to myelodysplastic syndromes with detectable mutations.
2021
-
Survival of patients with marginal zone lymphoma in the United States: A population-based cohort study (2000 to 2017)..
96.
2021
-
Granulocyte-colony stimulating factor in COVID-19: Is it stimulating more than just the bone marrow?.
95.
2020
-
Accelerated thrombin times are associated with thrombotic risk..
95.
2020
-
Impact of bone marrow fibrosis grade in post-polycythemia vera and post-essential thrombocythemia myelofibrosis: A study of the MYSEC group..
95.
2019
-
Monoclonal gammopathy-associated thrombotic microangiopathy..
94.
2019
-
Maternal sensitization occurs before delivery in severe cases of fetal alloimmune thrombocytopenia..
94.
2019
-
Response to thrombopoietic agents is related to on-treatment bone marrow megakaryocyte morphology in patients with chronic immune thrombocytopenia..
94.
2019
-
Bone marrow biopsy in low-risk monoclonal gammopathy of undetermined significance reveals a novel smoldering multiple myeloma risk group..
94.
2019
-
Organ response in patients with AL amyloidosis treated with NEOD001, an amyloid-directed monoclonal antibody..
91.
2016
-
Lenalidomide in the treatment of Rosai Dorfman disease--a first in use report..
91.
2016
-
Flow cytometry detection of minimal residual disease in multiple myeloma: Lessons learned at FDA-NCI roundtable symposium..
89.
2014
-
Successful perioperative use of prothrombin complex concentrate in the treatment of acquired factor X deficiency in the setting of systemic light-chain (AL) amyloidosis..
89.
2014
-
Skin necrosis induced by generic enoxaparin..
88.
2013
-
Localized insulin-derived amyloidosis: a potential pitfall in the diagnosis of systemic amyloidosis by fat aspirate..
87.
2012
-
Thrombotic thrombocytopenic purpura complicating immune thrombocytopenic purpura--a case report..
86.
2011
-
Venous thrombosis associated with gene deletion of tissue factor pathway inhibitor..
84.
2009
-
Allopurinol-induced pure red cell aplasia..
73.
2003
-
Idiopathic thrombocytopenic purpura..
48.
1995
-
Acquired platelet storage pool deficiency due to severe valvular disease corrected by prosthetic valve replacement..
45.
1994
-
Does absence of intracranial hemorrhage in the first pregnancy in fetal and neonatal alloimmune thrombocytopenia preclude occurrence in the second?
2024
-
Long-term survival with oral azacitidine for patients with acute myeloid leukemia in first remission after chemotherapy: updated results from the randomized, placebo-controlled, phase 3 QUAZAR AML-001 trial.
2023
-
Hematological support of patients with significant anemia who decline red blood cell blood transfusion.
2022
-
Clinical Features Associated with Thrombotic Events in Children with Myeloproliferative Neoplasms.
2022
-
Outcomes of TP53-mutated AML with evolving frontline therapies: Impact of allogeneic stem cell transplantation on survival.
2022
-
Landscape and clinical significance of long non-coding RNAs involved in multiple myeloma expressed fusion transcripts.
2021
-
Multicenter evaluation of efficacy and toxicity of venetoclax-based combinations in patients with accelerated and blast phase myeloproliferative neoplasms.
2021
-
Serologic response to mRNA COVID-19 vaccination in lymphoma patients.
2021
-
Iron overload after complement inhibitor treatment of Paroxysmal Nocturnal Hemoglobinuria.
2021
-
The prognosis and durable clearance of RAS mutations in patients with acute myeloid leukemia receiving induction chemotherapy.
2021
-
Outcomes in CLL patients with NOTCH1 regulatory pathway mutations.
2021
-
Characterization of the severe phenotype of pyruvate kinase deficiency.
2020
-
Clinical and economic burden of regularly transfused adult patients with β-thalassemia in the United States: A retrospective cohort study using payer claims.
2019
-
Autologous stem cell transplant is feasible in very elderly patients with lymphoma and limited comorbidity.
2012
-
Fatal CMV pneumonitis in a lymphoma patient treated with rituximab.
2009
-
A novel beta-thalassemia intermedia phenotype containing Nt494+129T-->C and NT494+132C-->A mutations in cis and a Nt168C-->T (beta(o) 39 point) mutation in trans.
2001
-
Reality of complementary and alternative medicine in lymphoma patients: hope, hype, or help?.
84.
2009
-
Modern management of respiratory failure due to pulmonary mycoses following allogeneic hematopoietic stem-cell transplantation.
2005
-
Mortality in immune thrombocytopenic purpura: report of seven cases and consideration of prognostic indicators.
1994
-
Lymphomas following cardiac transplantation. Case report and review of the literature.
1991
-
CARs of the future.
2019
-
Determination of human platelet antigen typing by molecular methods: Importance in diagnosis and early treatment of neonatal alloimmune thrombocytopenia.
2012
-
Immunotherapy in mantle cell lymphoma: anti-CD20-based therapy and beyond.
2008
-
Benzene-induced acute myeloid leukemia: a clinician's perspective.
2007
Identity
ISO Abbreviation
Linking ISSN
International Standard Serial Number (ISSN)
Electronic International Standard Serial Number (EISSN)